Neuland Laboratories Ltd
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.(Source : 202003 Annual Report Page No: 103)
- Market Cap ₹ 2,617 Cr.
- Current Price ₹ 2,040
- High / Low ₹ 2,350 / 246
- Stock P/E 48.4
- Book Value ₹ 582
- Dividend Yield 0.10 %
- ROCE 7.80 %
- ROE 2.28 %
- Face Value ₹ 10.0
Pros
- No pros found. Suggest something.
Cons
- Stock is trading at 3.51 times its book value
- The company has delivered a poor sales growth of 10.21% over past five years.
- Company has a low return on equity of 2.38% for last 3 years.
- Dividend payout has been low at 5.31% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -15.43%
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
154 | 169 | 171 | 173 | 181 | 186 | 204 | 192 | 205 | 241 | 245 | |
145 | 154 | 156 | 154 | 162 | 161 | 176 | 162 | 172 | 201 | 199 | |
Operating Profit | 9 | 15 | 16 | 18 | 19 | 25 | 28 | 30 | 34 | 41 | 47 |
OPM % | 6% | 9% | 9% | 11% | 10% | 13% | 14% | 16% | 16% | 17% | 19% |
Other Income | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 |
Interest | 4 | 4 | 3 | 5 | 4 | 5 | 6 | 7 | 5 | 4 | 4 |
Depreciation | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 | 10 |
Profit before tax | 1 | 5 | 6 | 8 | 8 | 12 | 16 | 17 | 20 | 29 | 32 |
Tax % | 20% | 17% | 22% | 19% | 25% | 30% | 29% | 154% | 25% | 25% | 16% |
Net Profit | 1 | 5 | 5 | 7 | 6 | 9 | 11 | -9 | 15 | 21 | 27 |
EPS in Rs | 0.44 | 3.55 | 3.66 | 5.18 | 4.45 | 6.77 | 8.66 | -7.25 | 11.82 | 16.71 | 20.84 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
307 | 278 | 397 | 448 | 461 | 466 | 469 | 510 | 579 | 527 | 667 | 763 | 884 | |
281 | 254 | 349 | 401 | 402 | 395 | 402 | 430 | 472 | 477 | 608 | 661 | 732 | |
Operating Profit | 26 | 24 | 48 | 47 | 58 | 71 | 67 | 80 | 106 | 51 | 58 | 102 | 151 |
OPM % | 8% | 9% | 12% | 11% | 13% | 15% | 14% | 16% | 18% | 10% | 9% | 13% | 17% |
Other Income | 11 | 5 | 3 | 2 | 3 | 3 | 0 | 2 | 1 | 4 | 3 | 4 | 3 |
Interest | 14 | 26 | 30 | 33 | 31 | 25 | 27 | 24 | 21 | 19 | 16 | 22 | 20 |
Depreciation | 7 | 14 | 15 | 15 | 15 | 15 | 15 | 16 | 19 | 22 | 26 | 31 | 36 |
Profit before tax | 15 | -10 | 5 | 1 | 16 | 35 | 25 | 42 | 67 | 14 | 20 | 53 | 98 |
Tax % | 18% | 30% | -7% | -210% | 12% | 23% | 36% | 36% | 30% | 13% | 19% | 69% | |
Net Profit | 12 | -7 | 5 | 3 | 14 | 27 | 16 | 27 | 47 | 12 | 16 | 16 | 54 |
EPS in Rs | 13.39 | -7.75 | 5.94 | 2.88 | 15.57 | 30.12 | 17.96 | 30.75 | 52.74 | 13.57 | 12.81 | 12.63 | 42.12 |
Dividend Payout % | 16% | -0% | -0% | -0% | 7% | 9% | 8% | 7% | -0% | -0% | -0% | 16% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 10% |
3 Years: | 10% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | -0% |
3 Years: | -30% |
TTM: | 68% |
Stock Price CAGR | |
---|---|
10 Years: | 36% |
5 Years: | 29% |
3 Years: | 42% |
1 Year: | 401% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 5% |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 | 5 | 5 | 5 | 8 | 8 | 9 | 9 | 9 | 9 | 13 | 13 | 13 | |
Reserves | 70 | 63 | 68 | 71 | 92 | 116 | 152 | 178 | 537 | 549 | 686 | 697 | 734 |
Borrowings | 200 | 233 | 234 | 220 | 211 | 190 | 188 | 182 | 192 | 319 | 231 | 260 | 224 |
95 | 97 | 121 | 130 | 114 | 169 | 162 | 155 | 148 | 194 | 200 | 261 | 344 | |
Total Liabilities | 371 | 398 | 428 | 426 | 425 | 483 | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,314 |
147 | 163 | 158 | 151 | 136 | 131 | 123 | 139 | 466 | 475 | 542 | 653 | 665 | |
CWIP | 37 | 30 | 27 | 27 | 36 | 35 | 41 | 40 | 20 | 126 | 104 | 24 | 54 |
Investments | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 |
181 | 198 | 235 | 240 | 246 | 311 | 340 | 337 | 393 | 463 | 476 | 547 | 587 | |
Total Assets | 371 | 398 | 428 | 426 | 425 | 483 | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,314 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
22 | 15 | 32 | 49 | 26 | 49 | 13 | 45 | 39 | 11 | 70 | 57 | |
-74 | -23 | -8 | -5 | -7 | -10 | -14 | -20 | -42 | -116 | -77 | -49 | |
55 | 10 | -24 | -44 | -20 | -39 | 1 | -24 | -0 | 105 | 12 | -5 | |
Net Cash Flow | 2 | 2 | -0 | 0 | -1 | -0 | 0 | 1 | -4 | -0 | 5 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 5% | 11% | 11% | 15% | 19% | 16% | 19% | 16% | 4% | 4% | 8% | |
Debtor Days | 85 | 95 | 92 | 78 | 78 | 93 | 100 | 85 | 114 | 134 | 90 | 91 |
Inventory Turnover | 2.45 | 3.50 | 3.51 | 3.14 | 2.85 | 2.58 | 2.30 | 2.22 | 1.72 | 2.15 | 2.02 |
Documents
Add documentRecent announcements
- Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 15h
- Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 1d
- Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 1d
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 26 Feb
- Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 24 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2013 from nse
- Financial Year 2012 from bse
- Financial Year 2012 from nse
- Financial Year 2011 from bse
- Financial Year 2010 from bse
- Financial Year 2010 from nse